FRI0305 Phase 2 trial of induction therapy with anti-cd20 (RITUXIMAB) followed by maintenance therapy with anti-baff (BELIMUMAB) in patients with active lupus nephritis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.5711
Abstract: Background Despite case series suggesting efficacy, controlled trials of anti-CD20 in lupus nephritis (LN) did not confirm benefit;Arthritis Rheum 201264:1215 and 2013;65:2368). Objectives One possible explanation for this failure stems from the fact that B… read more here.
Keywords: group; anti baff; baff; anti cd20 ... See more keywords
Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
Sign Up to like & getrecommendations! Published in 2019 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics11100534
Abstract: The development of vaccines plays a vital role in the effective control of several fatal diseases. However, effective prophylactic and therapeutic vaccines have yet to be developed for completely curing deadly diseases, such as cancer,… read more here.
Keywords: using biomimetic; nanovaccines using; advances nanovaccines; recent advances ... See more keywords